Total Liabilities Summary of TaiMed Biologics Inc.

TaiMed Biologics Inc.'s latest annual total liabilities in 2023 was 1.32 Billion TWD , down -4.21% from previous year.
TaiMed Biologics Inc.'s latest quarterly total liabilities in 2024 Q2 was 1.05 Billion TWD , down -17.66% from previous quarter.
TaiMed Biologics Inc. reported annual total liabilities of 1.38 Billion TWD in 2022, down -16.96% from previous year.
TaiMed Biologics Inc. reported annual total liabilities of 1.66 Billion TWD in 2021, down -6.25% from previous year.
TaiMed Biologics Inc. reported quarterly total liabilities of 1.05 Billion TWD for 2024 Q2, down -17.66% from previous quarter.
TaiMed Biologics Inc. reported quarterly total liabilities of 1.32 Billion TWD for 2023 Q4, down -2.21% from previous quarter.

Annual Total Liabilities Chart of TaiMed Biologics Inc. (2023 - 2009)

Historical Annual Total Liabilities of TaiMed Biologics Inc. (2023 - 2009)

Year	Total Liabilities	Total Liabilities Growth
2023	1.32 Billion TWD	-4.21%
2022	1.38 Billion TWD	-16.96%
2021	1.66 Billion TWD	-6.25%
2020	1.78 Billion TWD	55.58%
2019	1.14 Billion TWD	61.05%
2018	710.55 Million TWD	237.22%
2017	210.71 Million TWD	139.48%
2016	87.98 Million TWD	230.38%
2015	26.63 Million TWD	-47.11%
2014	50.34 Million TWD	-11.66%
2013	56.99 Million TWD	300.43%
2012	14.23 Million TWD	-6.04%
2011	15.14 Million TWD	-10.24%
2010	16.87 Million TWD	-11.55%
2009	19.08 Million TWD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	1.27 Billion TWD	-3.85%
2024 Q2	1.05 Billion TWD	-17.66%
2023 Q4	1.32 Billion TWD	-2.21%
2023 Q1	1.39 Billion TWD	0.68%
2023 FY	1.32 Billion TWD	-4.21%
2023 Q3	1.35 Billion TWD	-0.83%
2023 Q2	1.36 Billion TWD	-1.89%
2022 Q2	1.7 Billion TWD	-10.18%
2022 Q1	1.89 Billion TWD	13.82%
2022 FY	1.38 Billion TWD	-16.96%
2022 Q4	1.38 Billion TWD	-18.64%
2022 Q3	1.7 Billion TWD	-0.15%
2021 Q4	1.66 Billion TWD	7.73%
2021 Q2	1.53 Billion TWD	-3.23%
2021 Q1	1.58 Billion TWD	-10.76%
2021 Q3	1.54 Billion TWD	0.78%
2021 FY	1.66 Billion TWD	-6.25%
2020 Q3	1.7 Billion TWD	-5.42%
2020 FY	1.78 Billion TWD	55.58%
2020 Q1	1.48 Billion TWD	29.57%
2020 Q2	1.8 Billion TWD	21.79%
2020 Q4	1.78 Billion TWD	4.24%
2019 Q4	1.14 Billion TWD	-9.91%
2019 FY	1.14 Billion TWD	61.05%
2019 Q1	639.03 Million TWD	-10.07%
2019 Q2	1 Billion TWD	57.45%
2019 Q3	1.27 Billion TWD	26.25%
2018 FY	710.55 Million TWD	237.22%
2018 Q4	710.55 Million TWD	11.54%
2018 Q3	637.02 Million TWD	-5.47%
2018 Q2	673.89 Million TWD	34.23%
2018 Q1	502.04 Million TWD	138.26%
2017 FY	210.71 Million TWD	139.48%
2017 Q4	210.71 Million TWD	10.79%
2017 Q3	190.19 Million TWD	-37.89%
2017 Q2	306.21 Million TWD	81.67%
2017 Q1	168.55 Million TWD	91.57%
2016 Q3	45.1 Million TWD	-14.88%
2016 Q1	57.99 Million TWD	117.76%
2016 FY	87.98 Million TWD	230.38%
2016 Q4	87.98 Million TWD	95.08%
2016 Q2	52.98 Million TWD	-8.63%
2015 Q3	147.15 Million TWD	72.95%
2015 FY	26.63 Million TWD	-47.11%
2015 Q4	26.63 Million TWD	-81.9%
2015 Q2	85.08 Million TWD	185.02%
2015 Q1	29.85 Million TWD	-40.71%
2014 Q2	13.29 Million TWD	0.0%
2014 Q4	50.34 Million TWD	0.0%
2014 Q1	- TWD	-100.0%
2014 FY	50.34 Million TWD	-11.66%
2013 Q1	14.19 Million TWD	-0.29%
2013 Q2	14.19 Million TWD	0.0%
2013 Q3	56.99 Million TWD	301.59%
2013 Q4	56.99 Million TWD	0.0%
2013 FY	56.99 Million TWD	300.43%
2012 Q3	14.23 Million TWD	157.7%
2012 Q2	5.52 Million TWD	0.0%
2012 Q4	14.23 Million TWD	0.0%
2012 FY	14.23 Million TWD	-6.04%
2011 FY	15.14 Million TWD	-10.24%
2011 Q2	17.11 Million TWD	0.0%
2011 Q4	15.14 Million TWD	0.0%
2010 Q4	16.87 Million TWD	0.0%
2010 FY	16.87 Million TWD	-11.55%
2009 FY	19.08 Million TWD	0.0%

Peer Total Liabilities Comparison of TaiMed Biologics Inc.

Name	Total Liabilities	Total Liabilities Difference
Bio Preventive Medicine Corp.	124.72 Million TWD	-964.577%
Genomics BioSci & Tech. Co.,Ltd.	368.33 Million TWD	-260.501%
Advagene Biopharma Co., Ltd.	7.97 Million TWD	-16556.247%
Taiwan Bio Therapeutics Co., Ltd	328.47 Million TWD	-304.249%
NaviFUS Corp.	53.4 Million TWD	-2386.538%
G&E Herbal Biotechnology Co., Ltd.	119.86 Million TWD	-1007.822%
TaiRx, Inc.	60.62 Million TWD	-2090.245%
Sinew Pharma Inc.	39.71 Million TWD	-3243.496%
Lin BioScience, Inc.	167.73 Million TWD	-691.651%
TaiwanJ Pharmaceuticals Co., Ltd.	6.61 Million TWD	-19964.007%
Lumosa Therapeutics Co., Ltd.	227.69 Million TWD	-483.167%
Anti-Microbial Savior BioteQ Co., Ltd	6.99 Million TWD	-18885.359%
SYN-TECH Chem. & Pharm. Co., Ltd.	583.48 Million TWD	-127.571%
AP Biosciences Inc	106.65 Million TWD	-1145.041%
Sunmax Biotechnology Co., Ltd.	732.98 Million TWD	-81.154%
RBC Bioscience Corporation	513.08 Million TWD	-158.797%
Syngen Biotech Co.,Ltd.	974.63 Million TWD	-36.24%
EirGenix Inc.	1.14 Billion TWD	-15.958%
Enimmune corporation	173.46 Million TWD	-665.487%
Lukas Biomedical Inc.	161.05 Million TWD	-724.441%
BRIM Biotechnology, Inc.	42.15 Million TWD	-3049.666%
3D Global Biotech Inc.	30.68 Million TWD	-4227.877%
Mycenax Biotech Inc.	1.32 Billion TWD	-0.35%
TCI GENE Inc.	155.54 Million TWD	-753.65%
SynCore Biotechnology Co.,Ltd	21.22 Million TWD	-6155.705%
Oneness Biotech Co., Ltd.	866.42 Million TWD	-53.254%
Eusol Biotech Co.,Ltd.	9.27 Million TWD	-14214.748%
Feng Chi Biotech Corp.	63.03 Million TWD	-2006.539%
NeoCore Technology Co., Ltd.	197.47 Million TWD	-572.421%
TWi Biotechnology, Inc.	55.81 Million TWD	-2279.08%
Neith Corporation	17.43 Million TWD	-7516.796%
Sunny Pharmtech Inc.	512.43 Million TWD	-159.122%
VBI	21.25 Million TWD	-6148.346%
Ever Supreme Bio Technology Co., Ltd	232.95 Million TWD	-469.987%
GeneReach Biotechnology Corp.	313.7 Million TWD	-323.274%
Shine-On BioMedical Co.,Ltd.	23.25 Million TWD	-5609.895%
CHO Pharma, Inc.	110.83 Million TWD	-1098.062%
Andros Pharmaceuticals Co.,Ltd	58.03 Million TWD	-2187.834%
MegaPro Biomedical Co., Ltd	25.5 Million TWD	-5105.567%
Visgeneer Inc.	185.6 Million TWD	-615.41%
Greenyn Biotechnology Co., Ltd	364.47 Million TWD	-264.314%
BioLASCO Taiwan Co., Ltd.	111.98 Million TWD	-1085.769%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	481.48 Million TWD	-175.778%
Sagittarius Life Science Corp	137.82 Million TWD	-863.429%
BioGend Therapeutics Co., Ltd.	93.71 Million TWD	-1316.902%
GlycoNex Incorporation	276.39 Million TWD	-380.406%
Medigen Biotechnology Corp.	3.53 Billion TWD	62.385%
Pharmosa Biopharm Inc.	195.99 Million TWD	-577.502%
PharmaEngine, Inc.	91 Million TWD	-1359.064%
Intech Biopharm Corporation	1.54 Billion TWD	13.957%
Taiwan Advance Bio-Pharmaceutical Inc.	514.65 Million TWD	-158.007%
BiOptic Inc.	170.56 Million TWD	-678.502%
TaiGen Biopharmaceuticals Holdings Limited	110.94 Million TWD	-1096.896%
Senhwa Biosciences, Inc.	46.17 Million TWD	-2775.66%
NatureWise Biotech & Medicals Corporation	64.88 Million TWD	-1946.382%
OBI Pharma, Inc.	650.44 Million TWD	-104.142%
Savior Lifetec Corporation	457.95 Million TWD	-189.948%
Great Novel Therapeutics Biotech & Medicals	26.81 Million TWD	-4852.21%
Level Biotechnology Inc.	273.2 Million TWD	-386.029%
Medigen Vaccine Biologics Corporation	2.24 Billion TWD	40.882%
Meribank Biotech Co., Ltd	390.81 Million TWD	-239.763%
Acepodia, Inc.	384.47 Million TWD	-245.366%
Caliway Biopharmaceuticals Co., Ltd.	85.55 Million TWD	-1452.062%

Global Stocks Search

TaiMed Biologics Inc. (4147.TWO)

Total Liabilities Summary of TaiMed Biologics Inc.

Annual Total Liabilities Chart of TaiMed Biologics Inc. (2023 - 2009)

Historical Annual Total Liabilities of TaiMed Biologics Inc. (2023 - 2009)

Peer Total Liabilities Comparison of TaiMed Biologics Inc.